Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3
Closed 157
2022
Q3
$0 Hold
3
﹤0.01% 743
2022
Q2
$0 Hold
3
﹤0.01% 738
2022
Q1
$0 Hold
3
﹤0.01% 743
2021
Q4
$0 Hold
3
﹤0.01% 752
2021
Q3
$0 Hold
3
﹤0.01% 832
2021
Q2
$0 Hold
3
﹤0.01% 801
2021
Q1
$0 Hold
3
﹤0.01% 799
2020
Q4
$0 Hold
3
﹤0.01% 747
2020
Q3
$0 Hold
3
﹤0.01% 732
2020
Q2
$0 Hold
3
﹤0.01% 720
2020
Q1
$0 Hold
3
﹤0.01% 675
2019
Q4
$0 Hold
3
﹤0.01% 670
2019
Q3
$0 Hold
3
﹤0.01% 689
2019
Q2
$0 Hold
3
﹤0.01% 675
2019
Q1
$0 Hold
3
﹤0.01% 656
2018
Q4
$0 Hold
3
﹤0.01% 632
2018
Q3
$0 Hold
3
﹤0.01% 668
2018
Q2
$0 Hold
3
﹤0.01% 649
2018
Q1
$0 Hold
3
﹤0.01% 646
2017
Q4
$0 Sell
3
-175
-98% -$14.1K ﹤0.01% 628
2017
Q3
$14K Buy
178
+156
+709% +$11.1K 0.01% 388
2017
Q2
$1K Hold
22
﹤0.01% 558
2017
Q1
$1K Hold
22
﹤0.01% 530
2016
Q4
$1K Buy
+22
New +$1.16K ﹤0.01% 523

Other funds holding ADNT

Hudock Inc's ADNT Position: Q4 2022 in Review

Hudock Inc sold out of Adient (ADNT) in Q4 2022, closing a stake of 3 shares.

Hudock Inc first reported a position in ADNT in Q4 2016 and held it in 24 quarters. The position peaked at $14K in Q3 2017. 273 funds tracked by Wall St. Rank hold ADNT as of Q4 2022.

  • Hudock Inc reported no remaining Adient position as of Q4 2022 after selling out during the quarter.
  • Hudock Inc sold 3 Adient shares in Q4 2022.
  • Hudock Inc first reported a position in Adient in Q4 2016 and held it in 24 quarters.
  • Hudock Inc's Adient position peaked at $14K in Q3 2017.
  • 273 funds tracked by Wall St. Rank held Adient as of Q4 2022.

Based on Hudock Inc's 13F filing for Q4 2022, filed 8 Feb 2023.